FIGHT AGAINST HIV/AIDS

Fight against HIV/AIDS



Role of government and pharmaceutical industry in the fight against HIV/AIDS

Introduction

Africa is a region of the world that is most affected by HIV / AIDS. As it hosts twenty five million or above sixty percent of individuals swallowing HIV / AIDS. Youth (aged 15-24 years) are among the most affected and have the highest bit of new transmissions while they represent the next manpower of African economic system. The epidemic is also found in the active adult population, which constitutes a serious handicap to economic growth in the countries concerned, and improving the living conditions of millions of public servants. (Iliffe, 2006, 155-187). The impact of HIV / AIDS on the government is composite, far-flung & manifests itself in several dimensions (multidimensional) and includes increased management costs in the small and extended term, reducing use, loss of profits, tax revenue and investment, intellectual capital, institutional memory, contacts / networks, and the deteriorating quality of basic services.

The battle against HIV / AIDS is a public service because the epidemic could undermine collective efforts for economic development. To this end, the business concern between government, pharmaceutical companies and professional organizations is critical to mobilize against the spread of the epidemic. (Kalipeni, Zulu, 2008, 33-53). HIV / AIDS is rising increasingly as the main obstacle to investment in Africa and reversing attempts to reduce poverty and to do so, it requires urgent and sustained efforts.

Government and pharmaceutical companies could play an important role in the battle against the eruption because they interact directly or indirectly with families, clients and community members. By merging their forces, private companies, government and civil society could take the opportunity to make their contributions to developing and sustaining a vibrant business environment and productive and justify a business perspective the need to take actions related to prevention, care and treatment. The interaction can be through media or through training programs. The pharmaceutical companies started campaigns at colleges. In these campaigns, youth get to know about the circumstances which one has to face during HIV/AIDS. (Kemp, 2002, 102-140)

Rationale and Objectives 

World Bank, through its Support Unit Mobilization against HIV / AIDS in Africa (ACT Africa) and the Department of Finance and Pharmaceutical companies of the Africa Region (AFRFP), in partnership with the Government of the Republic of Mali and the Pan-African Network of Business Coalitions (PABC) will hold three of the 3-5 December 2007, thematic consultations of partners' views Thematic Partners "on the pharmaceutical companies' role in the fight against HIV / AIDS. (Iliffe, 2006, 155-187). The views Tags Bamako follows similar activities held across the continent (i) the Pharmaceutical companies Forum: Strategies for pharmaceutical companies involvement in national programs against HIV / AIDS, organized Livingstone, Zambia, (ii) Meeting on Mobilizing the Pharmaceutical companies, held in Windhoek, Namibia, (iii) Sub-Regional Forum to mobilize the pharmaceutical companies, organized Blantyre, Malawi (iv) Workshop strategic mobilization of the pharmaceutical companies, held in Johannesburg, South Africa, and (v) Mobilization Forum cons of pharmaceutical companies HIV / AIDS for Francophone Africa, held in Marrakech, Morocco.

The overall objective of the Thematic Consultations Partners is to develop a platform and business ...